 Paula Yamashita
Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Panic | 4 | 2017 | 10 | 0.730 |
Why?
| | Avoidance Learning | 2 | 2014 | 69 | 0.450 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 17 | 0.410 |
Why?
| | Receptor, Serotonin, 5-HT2C | 1 | 2010 | 15 | 0.350 |
Why?
| | Anxiety | 3 | 2016 | 959 | 0.250 |
Why?
| | Maze Learning | 3 | 2016 | 104 | 0.240 |
Why?
| | Receptor, Serotonin, 5-HT1A | 2 | 2017 | 38 | 0.240 |
Why?
| | Escape Reaction | 4 | 2017 | 62 | 0.210 |
Why?
| | Arousal | 1 | 2023 | 150 | 0.200 |
Why?
| | Rats, Wistar | 5 | 2017 | 440 | 0.190 |
Why?
| | Psycholinguistics | 1 | 2019 | 20 | 0.160 |
Why?
| | Phobic Disorders | 1 | 2019 | 31 | 0.160 |
Why?
| | Anti-Anxiety Agents | 2 | 2016 | 45 | 0.160 |
Why?
| | Memory, Episodic | 1 | 2019 | 42 | 0.150 |
Why?
| | Emotions | 1 | 2023 | 535 | 0.150 |
Why?
| | Serotonin | 3 | 2017 | 320 | 0.140 |
Why?
| | Panic Disorder | 1 | 2017 | 23 | 0.130 |
Why?
| | Receptors, Opioid, mu | 1 | 2017 | 58 | 0.130 |
Why?
| | Hypothalamus | 1 | 2017 | 149 | 0.130 |
Why?
| | Fear | 1 | 2019 | 348 | 0.120 |
Why?
| | Immunomodulation | 1 | 2016 | 93 | 0.120 |
Why?
| | Learning | 1 | 2019 | 399 | 0.120 |
Why?
| | Serotonin Receptor Agonists | 2 | 2013 | 28 | 0.110 |
Why?
| | Serotonin Antagonists | 2 | 2013 | 31 | 0.110 |
Why?
| | Rats | 5 | 2017 | 5462 | 0.110 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2013 | 20 | 0.110 |
Why?
| | Public Health | 1 | 2016 | 482 | 0.090 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2019 | 822 | 0.090 |
Why?
| | Mental Health | 1 | 2016 | 685 | 0.080 |
Why?
| | Microbiota | 1 | 2016 | 725 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2003 | 0.060 |
Why?
| | Animals | 7 | 2019 | 35219 | 0.060 |
Why?
| | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2017 | 4 | 0.030 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 9 | 0.030 |
Why?
| | Somatostatin | 1 | 2017 | 55 | 0.030 |
Why?
| | Fenclonine | 1 | 2016 | 1 | 0.030 |
Why?
| | Moclobemide | 1 | 2016 | 1 | 0.030 |
Why?
| | Alprazolam | 1 | 2016 | 6 | 0.030 |
Why?
| | Sumatriptan | 1 | 2016 | 8 | 0.030 |
Why?
| | Male | 5 | 2017 | 63491 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2016 | 89 | 0.030 |
Why?
| | Naloxone | 1 | 2017 | 112 | 0.030 |
Why?
| | Locomotion | 1 | 2016 | 100 | 0.030 |
Why?
| | Clonazepam | 1 | 2014 | 6 | 0.030 |
Why?
| | Diazepam | 1 | 2014 | 34 | 0.030 |
Why?
| | Piperazines | 1 | 2017 | 342 | 0.030 |
Why?
| | Imipramine | 1 | 2013 | 12 | 0.030 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 1 | 2013 | 5 | 0.030 |
Why?
| | Pyridines | 1 | 2017 | 478 | 0.030 |
Why?
| | Fluoxetine | 1 | 2013 | 53 | 0.030 |
Why?
| | Models, Psychological | 1 | 2014 | 307 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2013 | 268 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 676 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2017 | 898 | 0.020 |
Why?
| | Depression | 1 | 2016 | 1302 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4049 | 0.020 |
Why?
| | Inflammation | 1 | 2016 | 2723 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2664 | 0.010 |
Why?
| | Humans | 3 | 2023 | 129212 | 0.010 |
Why?
|
|
Yamashita's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|